project . 2016 - 2017 . Closed


Surface modulation of wounds: heal by inhalants! Novel drug-based treatment for excessive scars and chronic wounds.
Open Access mandate for Publications
European Commission
Funder: European CommissionProject code: 693017 Call for proposal: ERC-2015-PoC
Funded under: H2020 | ERC | ERC-POC Overall Budget: 150,000 EURFunder Contribution: 150,000 EUR
Status: Closed
01 May 2016 (Started) 31 Dec 2017 (Ended)
Open Access mandate
Research data: No

The innovative concept of the ERC Starting Grant project “Keratinocytes and Matrix metalloproteinases: driving force of skin wound contraction?” was to use inhalants for skin wounds and it proved to be excellent and functional. Surface Modulation of Wounds (SUMOWO) with these anti-inflammatory, pro-migratory and anti-fibrotic compounds will be beneficial for chronic wound healing and reduce excessive scarring. This novel drug-based treatment strategy marks a novel era of wound care. A clinical phase 1 study on healthy volunteers is planned to show the product’s safety and tolerability for skin use – the first step towards clinical application. The goal of SUMOWO is to deliver clinical proof of concept, to provide a thorough market analysis with contact to key-players, to secure our intellectual property rights on an international platform, to accelerate commercial exploitation and ultimately, to restore patients’ life quality.

Data Management Plans